Study of Immediate Start of Progestin Contraceptives in Medical Abortion
NCT01902485 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 937
Last updated 2016-03-04
Summary
This study will compare immediate to post-abortion start of two progestin-based contraceptives (DMPA and etonorgestrel implants) among women having first trimester medical abortion who wish to use that method for post-abortion contraception.
Conditions
- Contraception
Interventions
- OTHER
-
Timing of Contraceptive Initiation in Medical Abortion
Sponsors & Collaborators
-
Gynuity Health Projects
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- United States
- Mexico
Study Locations
More Related Trials
-
Mifepristone and Misoprostol for Mid-trimester Termination of Pregnancy in Armenia
NCT01766388 ·Status: COMPLETED
-
De-Medicalizing Mifepristone Medical Abortion
NCT00120224 ·Status: COMPLETED
-
Mifepristone and Mid-Trimester Termination of Pregnancy
NCT00382538 ·Status: COMPLETED ·Phase: NA
-
Oral Contraceptive Pills Versus Expectant Management for Retained Pregnancy Products
NCT03230825 ·Status: UNKNOWN ·Phase: NA
-
Better Contraceptive Choices: Immediate or Delayed Insertion of IUC After Second Trimester Abortion
NCT00877344 ·Status: UNKNOWN ·Phase: PHASE4
-
A Randomized Study of Cervical Priming With Misoprostol Prior to Elective First Trimester Pregnancy Termination
NCT00310921 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Immediate Versus Delayed Initiation of Transdermal Hormonal Contraception After Therapeutic Abortion
NCT00235547 ·Status: COMPLETED ·Phase: NA
-
Intrauterine Contraception (IUC) After Medical Abortion
NCT01537562 ·Status: COMPLETED ·Phase: NA
-
Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)
NCT01768299 ·Status: COMPLETED ·Phase: PHASE4
-
Intrauterine Contraception After First Trimester Abortion - Effects on Quality of Life and Risk of Repeat Abortion.
NCT01223521 ·Status: COMPLETED ·Phase: NA
-
Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation
NCT02314754 ·Status: COMPLETED ·Phase: PHASE4
-
A Pilot of an Outpatient Regimen of Medical Abortion With Mifepristone and Sublingual Misoprostol in the 11 and 12 Weeks
NCT02720991 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing Medical Menstrual Regulation in the United States
NCT03972358 ·Status: UNKNOWN ·Phase: PHASE2
-
Mifepristone Versus Laminaria Insertion for Cervical Preparation Prior to Surgical Abortion at 14-16 Weeks
NCT00986921 ·Status: COMPLETED ·Phase: NA
-
Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days Gestation
NCT00330993 ·Status: COMPLETED ·Phase: PHASE2
-
Immediate Versus Delayed Insertion of Intrauterine Contraception After Medical Abortion
NCT03603145 ·Status: UNKNOWN ·Phase: PHASE3
-
Ideal Timing of Intrauterine Contraception Insertion After Medical Management of First Trimester Incomplete Abortion
NCT05343546 ·Status: UNKNOWN ·Phase: NA
-
IUD Insertion Post First Trimester Abortion
NCT01174225 ·Status: UNKNOWN ·Phase: PHASE4
-
Misoprostol for Non-Viable Pregnancies
NCT00426491 ·Status: COMPLETED ·Phase: PHASE3
-
Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation
NCT01856985 ·Status: COMPLETED ·Phase: PHASE4
-
Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation
NCT01966874 ·Status: COMPLETED
-
Mifepristone at Same Time Multicenter Study
NCT00269568 ·Status: COMPLETED ·Phase: PHASE4
-
Oral Progesterone for Prevention of Miscarriage in Threatened Abortion
NCT04788108 ·Status: COMPLETED ·Phase: PHASE4
-
Pain Control In First Trimester Medical Abortion: A Randomized Trial
NCT01457521 ·Status: COMPLETED ·Phase: PHASE4
-
Medication Abortion for Pregnancy of Unknown Location
NCT04026789 ·Status: UNKNOWN ·Phase: NA